Neurent Medical
Develops NEUROMARK, a minimally invasive solution to treat chronic rhinitis
€62.5MSeries C
Role not disclosedLoading investors…
Activity from announced rounds
Develops NEUROMARK, a minimally invasive solution to treat chronic rhinitis